
Thomas Cherpes Thomas Cherpes, University of Pittsburgh School of Medicine One thought provoking study at ICAAC explored the possible link between pelvic inflammatory disease, or PID, and herpes simpl

Matt Page Matt Page, United Biosource, MEDTAP Institute, Bethesda Vaccinating all age groups against influenza is likely to be cost effective – that’s acccording to a study presented at IC

Klaus Stohr Klaus Stohr, World Health Organisation, Geneva One of the keynote speeches in Washington described how avian influenza still looms large on the global health horizon. With the disease like

Bala Hota Bala Hota, Cook County Hospital, Chicago Researchers are now seeing growing numbers of MRSA infections in the community as well as in hospitals. One study presented at ICAAC was looking at p

Nick Lintzeris Nick Lintzeris of London’s Institute of Psychiatry A urine test which can distinguish between medicinally prescribed opiates and street heroin has been developed in London. France

Sandra Horning Abstract 349 Sandra Horning, Stanford University Medical Center It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therap

Vincent Rajkumar Vincent Rajkumar, Divison of Hematology, Mayo Clinic At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkuma

Owen O’Connor Owen O’Connor, Memorial Sloan-Kettering Cancer Center, New York Owen O’Connor also gave data from early, two studies: one looking at treating lymphoma with the drug SAH

Dennis Slamon, UCLA School of Medicine, Los Angeles It may be reasonable to replace the anthracycline component of adjuvant chemotherapy with carboplatin in HER-2 positive patients with early breast c

Reporting from: – 2005 Multidisciplinary Prostate Cancer Symposium, February 17-19, Hyatt Grand Cypress, Orlando, Florida In this edition: Will they or won’t they relapse? For patients wit

Reporting from: – Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego – Lymphoma: The Next Questions, April 8-9, 2005, Fort Lauderdale – Journal of Cl

Reporting from: ECCO-13 The European Cancer Conference, Paris, October 30–November 3, 2005 In this edition: Martine Piccart gave the Paris ECCO conference her group’s latest data from the